-
Alabduljabbar K, Alsaqaaby M, Neff KJ, Crotty M, le Roux CW.
Weight loss response in patients with obesity treated with injectable semaglutide in a real-world setting Endocrine
- Thompson AS, Candussi CJ, Tresserra-Rimbau A, Jennings A, Bondonno NP, Hill C, Sowah SA, Cassidy A, Kühn T. A healthful plant-based diet is associated with lower type 2 diabetes risk via improved metabolic state and organ function: A prospective cohort study Diabetes Metab
-
Harrington S.
Shifting landscapes: The environmental impact of urbanisation on childhood myopia, obesity and diabetes Ophthalmic Physiol Opt
- Kueh MTW, Chew NWS, Al-Ozairi E, le Roux CW. The emergence of obesity in type 1 diabetes Int J Obes (Lond)
- Bailey CJ, Flatt PR, Conlon JM. Recent advances in peptide-based therapies for obesity and type 2 diabetes Peptides
-
Farrell E.
The importance of diversity in Obesity articles Obesity (Silver Spring)
-
Davey MG, Donlon NE, Fearon NM, Heneghan HM, Conneely JB.
Evaluating the Impact of Enhanced Recovery After Surgery Protocols on Surgical Outcomes Following Bariatric Surgery-A Systematic Review and Meta-analysis of Randomised Clinical Trials Obes Surg
-
Verma R, Dhingra NK, Connelly KA.
Obesity/cardiometabolic phenotype of heart failure with preserved ejection fraction: mechanisms to recent trials Curr Opin Cardiol
-
de Lemos JA, Linetzky B, le Roux CW, Laffin LJ, Vongpatanasin W, Fan L, Hemmingway A, Ahmad NN, Bunck MC, Stefanski A.
Tirzepatide Reduces 24-Hour Ambulatory Blood Pressure in Adults With Body Mass Index ≥27 kg/m(2): SURMOUNT-1 Ambulatory Blood Pressure Monitoring Substudy Hypertension
-
Bailey CJ, Flatt PR.
Duodenal enteroendocrine cells and GIP as treatment targets for obesity and type 2 diabetes Peptides